- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prime editing for functional repair in patient-derived disease models ; volume:11 ; number:1 ; day:23 ; month:10 ; year:2020 ; pages:1-8 ; date:12.2020
Nature Communications ; 11, Heft 1 (23.10.2020), 1-8, 12.2020
- Creator
-
Schene, Imre F.
Joore, Indi P.
Oka, Rurika
Mokry, Michal
Vugt, Anke H. M. van
Boxtel, Ruben van
Doef, Hubert P. J. van der
Laan, Luc J. W. van der
Verstegen, Monique M. A.
Hasselt, Peter M. van
Nieuwenhuis, Edward E. S.
Fuchs, Sabine A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-020-19136-7
- URN
-
urn:nbn:de:101:1-2020120419322255797499
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schene, Imre F.
- Joore, Indi P.
- Oka, Rurika
- Mokry, Michal
- Vugt, Anke H. M. van
- Boxtel, Ruben van
- Doef, Hubert P. J. van der
- Laan, Luc J. W. van der
- Verstegen, Monique M. A.
- Hasselt, Peter M. van
- Nieuwenhuis, Edward E. S.
- Fuchs, Sabine A.
- SpringerLink (Online service)
Other Objects (12)
Enhancing prime editing via inhibition of mismatch repair pathway
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Prime editing: therapeutic advances and mechanistic insights
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
CRISPR/Cas9 or prime editing? – It depends on…
Prime time for base editing in the mitochondria
Modeling C9ORF72 pathomechanisms in patient-derived cells
Patient-derived xenograft models in hepatopancreatobiliary cancer
Patient-derived xenografts as preclinical neuroblastoma models
Enhancing prime editing via inhibition of mismatch repair pathway
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Prime editing: therapeutic advances and mechanistic insights
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
CRISPR/Cas9 or prime editing? – It depends on…
Prime time for base editing in the mitochondria
Modeling C9ORF72 pathomechanisms in patient-derived cells
Patient-derived xenograft models in hepatopancreatobiliary cancer
Patient-derived xenografts as preclinical neuroblastoma models
Enhancing prime editing via inhibition of mismatch repair pathway
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants
Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer
Functional correction of X-CGD patient-derived induced pluripotent stem cells by targeted genome editing
Prime editing: therapeutic advances and mechanistic insights
CRISPR/Cas9 genome editing in LGMD2A/R1 patient-derived induced pluripotent stem and skeletal muscle progenitor cells
CRISPR/Cas9 or prime editing? – It depends on…
Prime time for base editing in the mitochondria
Modeling C9ORF72 pathomechanisms in patient-derived cells
Patient-derived xenograft models in hepatopancreatobiliary cancer